Regeneron Pharmaceuticals Inc., current enterprise value calculation

Current share price (P)	$828.84
No. shares of common stock outstanding	109,889,531
US$ in thousands
Common equity (market value)¹	91,080,839)
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (per books)	—)
Total equity	91,080,839)
Add: Finance lease liabilities, current portion (per books)	—)
Add: Long-term debt (per books)	1,982,900)
Add: Finance lease liabilities, excluding current portion (per books)	720,000)
Total equity and debt	93,783,739)
Less: Cash and cash equivalents	2,730,000)
Less: Marketable securities	8,114,800)
Enterprise value (EV)	82,938,939)

¹ Common equity (market value) = Share price × No. shares of common stock outstanding
= 828.84 × 109,889,531

Regeneron Pharmaceuticals Inc., EV calculation

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Share price^1, 2	$936.33	$780.86	$622.36	$494.90	$381.87
No. shares of common stock outstanding¹	109,761,896	109,325,532	108,539,282	107,131,899	110,019,809
US$ in thousands
Common equity (market value)³	102,773,356)	85,367,935)	67,550,508)	53,019,577)	42,013,264)
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (book value)	—)	—)	—)	—)	—)
Total equity	102,773,356)	85,367,935)	67,550,508)	53,019,577)	42,013,264)
Add: Finance lease liabilities, current portion (book value)	—)	—)	719,700)	—)	—)
Add: Long-term debt (book value)	1,982,900)	1,981,400)	1,980,000)	1,978,500)	—)
Add: Finance lease liabilities, excluding current portion (book value)	720,000)	720,000)	—)	717,200)	713,900)
Total equity and debt	105,476,256)	88,069,335)	70,250,208)	55,715,277)	42,727,164)
Less: Cash and cash equivalents	2,730,000)	3,105,900)	2,885,600)	2,193,700)	1,617,800)
Less: Marketable securities	8,114,800)	4,636,400)	2,809,100)	1,393,300)	1,596,500)
Enterprise value (EV)	94,631,456)	80,327,035)	64,555,508)	52,128,277)	39,512,864)

¹ Data adjusted for splits and stock dividends.

² Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.

³ 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 936.33 × 109,761,896

Download chart

Item	Description	The company
EV	Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.	Regeneron Pharmaceuticals Inc. EV increased from 2021 to 2022 and from 2022 to 2023.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Enterprise Value (EV)